Before CD44 was discovered to be a PRG4 receptor, its relevance in carcinogenesis was extensively acknowledged, being related to cancer stemness, increased traits of aggressiveness, and resistance to drugs in a spectrum of solid tumors including HCC [44–46]. Here, CD44 is linked to hepatocellular carcinoma.